OVERVIEW OF PROFESSIONALS MARIA THERESA REDANIEL, PH.D. Suicide
prevention specialist whos main focus is finding ways to prevent
suicide cases within local communities. She is looking to branch
out from the community sector to further her expertise on a federal
and state vocation. Received her masters from the University of
Nebraska in Community Development. MICHAEL BAUER, M.D., PH.D.
Mental health profession with interest in suicide risk assessments,
homicide and product liability especially in relation to
psychotropic drugs. He has extensive background in the field and
wishes to further his resume by succeeding as a mentor to upcoming
peers in the field. Graduated top of his class from the University
of Illinois 1965.
Slide 4
SUICIDE AND PREVENTION Effective protective care is essential
to suicide prevention. IF YOU ARE IN CRISIS, CALL 1-800-273-TALK
(8255) NATIONAL SUICIDE PREVENTION LIFELINE Suicide is the 10 th
leading cause of death in the united states (AFSP, 2014). And the
third leading cause among youth and young adults (Wharff, Ross,
& Lambert, 2014) Research shows 90% of those who have died by
suicide had a potentially treatable mental illness (AFSP, 2014).
Prevention starts with awareness and education. Risk Factors may
include mental disorder, previous attempts, family history, serious
medical condition or pain. These factors combined with
environmental stimuli increase chances of suicide and suicide
attempts (Carlborg, Winnerback, Jonsson, Jokinen & Nordstrom,
(2010).
Slide 5
RESEARCH Marias focus has been in the community prevention. The
barriers of suicide documentation in the Philippines has encouraged
her research in using psychological autopsys to evaluate a course
of intervention (AFSP, 2014). Psychological autopsies have been
used to present evidence of mental disorders present in those who
died from suicide based on a collection of interviews and reports
to dictate what they may have thought (Hjelmeland, Dieserud,
Dyregrov, Knizek & Leenaars, 2012). Michael has focused his
research in the use of pharmacology in suicide prevention. Giving
participants a prescribed amount of lithium has shown great strides
in lowering future suicide attempts and depressive behaviors (ASFP,
2014).
Slide 6
COMPARISON Maria has strong views in behavior aspect of study.
She has culminated research of behaviors related to mental
disorders and compared them to suicide reports made from informant
interviews and medical documents. She uses such information to
hopefully reduce the suicide rates in the community by early
diagnosis and treatment prevention. Michael uses his successful
career in clinical psychology to establish the benefits of treating
mental disorders to prevent suicides and suicidal behaviors. He
focuses his research to provide evidence of pharmacology on
disorders. His goal it to use such evidence to reduce thoughts of
suicide and attempts.
Slide 7
REFERENCES American Foundation for Suicide Prevention (AFSP)
(2014). Understanding Suicide. Retrieved June 10, 2014, from
http://www.afsp.org/understanding-suicidehttp://www.afsp.org/understanding-suicide
Carlborg, A., Winnerback, K., Jonsson, E., Jokinen, J., &
Nordstrom, P. (2010). Suicide in schizophrenia. Expert Review Of
Neurotherapeutics, (7), 1153. Hjelmeland, H., Dieserud, G.,
Dyregrov, K., Knizek, B. L., & Leenaars, A. A. (2012).
Psychological autopsy studies as diagnostic tools: are they
methodologically flawed?. Death Studies, (7), 605. Wharff, E. A.,
Ross, A. M., & Lambert, S. (2014). Field Note-Developing
Suicide Risk Assessment Training for Hospital Social Workers: An
Academic-Community Partnership. Journal Of Social Work Education,
50(1), 184-190. doi:10.1080/10437797.2014.856249